Contact Us
Home Jazz Pharmaceuticals Announces Fourth Quarter and Full Year 2010 Results Conference Call on March 7

News Release

Media Contact

Kristin Bhavnani
Head of Global Corporate Communications
Jazz Pharmaceuticals plc

Send Email
Ireland: +353 1 637 2141
US: 215-867-4948

Jazz Pharmaceuticals Announces Fourth Quarter and Full Year 2010 Results Conference Call on March 7

February 28, 2011
PDF Version

PALO ALTO, Calif., Feb. 28, 2011 /PRNewswire via COMTEX/ --

Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) today announced that it will host a conference call and live webcast on Monday, March 7, 2011 at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time. During the call, company management will provide a business update, review fourth quarter and full year 2010 results, and provide 2011 financial guidance.

The live webcast and press release may be accessed from the Investors section of the Jazz Pharmaceuticals' website at www.jazzpharmaceuticals.com. Please connect to the website prior to the start of the conference call to ensure adequate time for any software downloads that may be necessary to listen to the webcast. An archived version of the webcast will be available for at least one week.

Investors may participate in the conference call by dialing 1-866-362-4829 in the U.S., or 1-617-597-5346 outside the U.S., and entering passcode 60782035.

About Jazz Pharmaceuticals, Inc.

Jazz Pharmaceuticals (Nasdaq: JAZZ) is a specialty pharmaceutical company that identifies, develops and commercializes innovative treatments for important, underserved markets in neurology and psychiatry. For further information see www.jazzpharmaceuticals.com.

SOURCE Jazz Pharmaceuticals, Inc.